Bamco Inc Ascendis Pharma A/S Transaction History

Bamco Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $2.76 Million - $3.67 Million	27,806 Added 370.75%	35,306 $4.31 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $630,225 - $826,725	7,500 New	7,500 $774,000
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $2.09 Million - $2.78 Million	-20,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $2.61 Million - $3.48 Million	20,500 New	20,500 $2.76 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.